Choose date and time: ×
In the last 4 hours
In the last 6 hours
In the last 8 hours
Earlier today
Is Amgen's Dividend Sustainable? Seeking Alpha 23:38 30-Sep-16
AbbVie’s HCV regimen receives FDA breakthrough designation European Pharmaceutical Review 22:22 30-Sep-16
Speeding up biotech U-T San Diego 21:34 30-Sep-16
Biopharma's Other Worrisome Election Bloomberg 18:39 30-Sep-16
Gilead’s Growth Tonic Is Elusive, May Have Side Effects The Wall Street Journal 17:44 30-Sep-16
Regeneron slips on trial setback for Eylea combo BioPharma Dive 17:11 30-Sep-16
Regeneron slips on trial setback for Elyea combo BioPharma Dive 16:40 30-Sep-16
Bluebird flies into TCR deal with Medigene BioPharma Dive 16:40 30-Sep-16
SEC Issues Charges Over Biotech Insider Activity 24/7 Wall St. 14:23 30-Sep-16
A Look At Sage Therapeutics Seeking Alpha 14:13 30-Sep-16
Genentech and Hanmi strike $900m cancer deal pharmaphorum 12:03 30-Sep-16
Progress in neurology for Celgene and GW pharmaphorum 11:42 30-Sep-16
Mirae Asset chairman increases biotech investment The Korea Herald 09:41 30-Sep-16
OxyMem cleans up at EuropaBio Awards 08:58 30-Sep-16
Finding the right formula for vaccine production The Irish Times 06:17 30-Sep-16
Stock Market Nasty Pullback Day The Market Oracle 06:09 30-Sep-16
Hanmi Pharm Signs W1 Trillion Cancer Drug Deal The Chosun Ilbo 05:07 30-Sep-16
In the last 7 days
Iswaran visits AbbVie's Singapore plant The Straits Times 22:06 29-Sep-16
Philly-based Spark Therapeutics is racing to develop gene therapy for hemophilia The Philadelphia Inquirer, Pennsylvania 21:22 29-Sep-16
Tough conditions remain for IPOs U-T San Diego 20:56 29-Sep-16
Lonza to expand Pearland biotech facility Houston Chronicle, Texas 20:22 29-Sep-16
Seeds of discontent? The Hindu 19:54 29-Sep-16
Foamix Spots Dermatology Opportunity Seeking Alpha 17:12 29-Sep-16
As Repatha flounders, Amgen bolsters CV pipeline BioPharma Dive 16:21 29-Sep-16
Athlone firm OxyMem wins €10k biotech award The Westmeath Independent 16:20 29-Sep-16
Why Arrowhead Pharmaceuticals Stock Spiked Today The Motley Fool 16:03 29-Sep-16
Getting it right on value frameworks The Hill 15:15 29-Sep-16
Alexion Pharma Receives $194 Price Target Seeking Alpha 14:09 29-Sep-16
UCD spinout OxyMem wins European biotech award The Irish Times 13:57 29-Sep-16

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.